SecBot SecBot
← Back to Analyst Consensus
DRUG Buy

BRIGHT MINDS BIOSCIENCES INC.

Current Price —
Implied Upside —
Analysts 7

30-Day Momentum

▲ 1 upgrades  /  ▼ 0 downgrades  /  0 reiterations  from 1 firms

Rating Timeline

Date ▼FirmActionFrom → To RatingPrice TargetFirm Rating
Oct 15, 2026Wolfe Researchinitiate— → Outperform—53%
Aug 19, 2026HC Wainwright & Co.reiterateBuy → Buy—44%
Aug 17, 2026BTIGreiterateBuy → Buy—52%
Jun 1, 2026HC Wainwright & Co.reiterateBuy → Buy—44%
May 20, 2026Piper SandlermaintainOverweight → Overweight—54%
Apr 13, 2026Jefferiesinitiate— → Buy—52%
Mar 30, 2026BTIGreiterateBuy → Buy—52%
Mar 4, 2026HC Wainwright & Co.maintainBuy → Buy—44%
Feb 17, 2026BTIGmaintainBuy → Buy$14752%
Jan 7, 2026BTIGmaintainBuy → Buy$14752%
Jan 6, 2026BTIGmaintainBuy → Buy$14752%
Jan 2, 2026Chardan CapitalmaintainBuy → Buy$8047%
Dec 30, 2025HC Wainwright & Co.reiterateBuy → Buy$11544%
Sep 15, 2025HC Wainwright & Co.reiterateBuy → Buy$8544%
Sep 8, 2025BTIGinitiate— → Buy$7252%
Aug 19, 2025HC Wainwright & Co.reiterateBuy → Buy$8544%
May 21, 2025Chardan CapitalmaintainBuy → Buy$8047%
May 13, 2025TD Coweninitiate— → Buy$054%
May 7, 2025Chardan Capitalinitiate— → Buy$8047%
Feb 19, 2025HC Wainwright & Co.reiterateBuy → Buy$8544%
Jan 23, 2025Piper Sandlerinitiate— → Overweight$9354%
Jan 10, 2025Cantor Fitzgeraldinitiate— → Overweight$050%
Jan 10, 2025HC Wainwright & Co.initiate— → Buy$8544%
Nov 25, 2024Bairdinitiate— → Outperform$7555%

Price Target Trend

Apr 21, 2026 Latest: $154.51 Oct 24, 2026

EPS Estimates

0y $-3.76
Lo: $-4.47 Hi: $-2.85
8 analysts
▲6
+1q $-1.82
Lo: $-2.72 Hi: $-1.21
5 analysts
▲4
0q $-1.45
Lo: $-2.12 Hi: $-0.61
8 analysts
▲5
+1y $-8.11
Lo: $-13.48 Hi: $-4.24
8 analysts
▲5

Cross-Platform Signals

No cross-platform signals in the last 90 days

Fresh Analyst Detail

Price targets, earnings estimates, and firm actions for this ticker — updated within the last 24 hours.

Subscribe for Full Access